Patents by Inventor Denise DEVORE

Denise DEVORE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING MUSCLE WEAKNESS WITH ALKALINE PHOSPHATASES
    Publication number: 20260306590
    Abstract: The disclosure features methods for treating or ameliorating at least one symptom of a subject having or being prone to a muscle weakness disease by administering to the subject a therapeutically effective amount of at least one recombinant polypeptide having alkaline phosphatase activity. The subject is characterized as lacking a loss-of-function mutation in an ALPL gene.
    Type: Application
    Filed: March 26, 2024
    Publication date: October 8, 2026
    Inventors: Denise DEVORE, Anna PETRYK, Walter VOEGTLI, Derek DUNN, Juan RUANOVA
  • Treating seizure with recombinant alkaline phosphatase
    Patent number: 11224638
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: January 18, 2022
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Andre Marozsan, Denise Devore, Susan Liu-Chen
  • TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE
    Publication number: 20200093898
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Application
    Filed: October 18, 2019
    Publication date: March 26, 2020
    Inventors: Andre MAROZSAN, Denise DEVORE, Susan LIU-CHEN
  • Treating seizure with recombinant alkaline phosphatase
    Patent number: 10449236
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: October 22, 2019
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Andre Marozsan, Denise Devore, Susan Liu-Chen
  • TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE
    Publication number: 20170360899
    Abstract: The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Inventors: Andre MAROZSAN, Denise DEVORE, Susan LIU-CHEN